Greater Cannabis Company (GCAN) Revenue Growth (1y) (2018 - 2021)

Greater Cannabis Company (GCAN) Revenue Growth (1y) (2018 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Haleon 89.78 Bn 87.91 Bn - -
2 Teva Pharmaceutical Industries 36.02 Bn 32.28 Bn 1.97 Bn 2.34%
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn 2.91%
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -11.85%
5 United Therapeutics 23.09 Bn 20.94 Bn 648.10 Mn -1.62%
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.35 Bn 18.54 Bn 1.16 Bn 7.85%
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn 42.25%
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 14.92%
10 Greater Cannabis Company 236,233.75 234,794.75 - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -73.71%
Dec 31, 2019 -94.82%
Jun 30, 2018 30,671.23%